quanta biodesign品牌介绍
品牌简介
Quanta BioDesign公司由Paul D. Davis博士于1997年创立。1999年春天BioOrganic Technologies LLC更名为Quanta BioDesign。公司致力于研究开发各种分立聚乙二醇（dPEG®）聚乙二醇化试剂，以方便的用于诊断，治疗，肽合成，寡核苷酸合成和纳米技术等的应用中。我们的单分子量乙二醇偶联技术dPEG®可以消除诊断和治疗产品开发中发现的常见问题，如聚集和非特异性相互作用，水溶性差，递送不良，递送问题，血清半短毒性和抗原性。 dPEG®系列产品可定制，以满足广泛的诊断和治疗中的特定物理，化学和形态学要求。 Quanta BioDesign参与开发纳入dPEG®技术的新型交联和标记化学品，并在治疗和诊断领域将允许采取新的方法。
Quanta BioDesign, Ltd. was founded for the purpose of developing and commercializing an extensive line of products for companies involved in drug discovery and diagnostic development programs. The company was founded in 1997 by Paul D. Davis, Ph.D. under the name BioOrganic Technologies, LLC. In the spring of 1999 the name was changed to Quanta BioDesign, Ltd., to better reflect the company’s mission. All of our products are based on our proprietary discrete polyethylene glycol (dPEG®) chemistries, including our processes for making these compounds. Our single molecular weight ethylene glycol conjugation technology, dPEG®, can eliminate common problems found in the development of diagnostic and therapeutic products, such as aggregation and non-specific interactions, poor water solubility, poor delivery, delivery issues/options, short serum half-life, toxicity and antigenicity. The dPEG® product line can be custom tailored to meet specific physical, chemical and morphological requirements in a broad array of diagnostic and therapeutic applications. Quanta BioDesign is involved in developing new cross-linking and labeling chemistries that incorporate the dPEG® technology, and will allow for new approaches in the area of therapeutic and diagnostic development.
main products
Featured AQ Life Science Research Products
Q-Bright Chemiluminescent HRP Substrates
AQuora Fluorescent Dyes
AQ Secondary Antibodies & Conjugates
Featured dPEG® Products
Phospholipid dPEG® Derivatives
Amine & Thiol Reactive Crosslinkers
Protected Linkers & Building Blocks
https://www.quantabiodesign.com
联系我们
